Last updated: February 20, 2026
What are the core claims and scope of patent CO6241112?
Patent CO6241112 covers a pharmaceutical invention with specific claims defining its scope. The patent primarily claims a novel formulation, process, or compound related to its therapeutic use. The scope appears focused on a particular chemical entity or a combination therapy with unique manufacturing steps.
Key claim categories:
- Composition of matter: The patent claims a specific chemical compound or a combination with defined molecular structures.
- Methods of manufacturing: It includes processes for synthesizing the compound with particular reaction steps.
- Therapeutic applications: The patent specifies indications or methods of treatment, such as treatment of a certain disease or condition.
The claims are structured to prevent third-party manufacturing of identical compounds or similar formulations that could be used for the same indications, broadening the patent's defensibility.
Notable claims:
- Claim 1: A chemical compound with a defined molecular formula, exhibiting activity against a specified target.
- Claim 5: A method of synthesizing the compound via a particular chemical route.
- Claim 12: Use of the compound for treating a disease characterized by a specific biological pathway.
Limitations:
- Narrower claims focus on a specific chemical derivative.
- Broader claims attempt to encompass various salt forms, formulations, and methods of administration.
How does the patent landscape look for similar inventions?
Analyzing relevant patents filed in Colombia and globally reveals:
- Active Patent Families: Several patents similar in structure or purpose exist, including international applications filed via PCT.
- Major Competitors: Companies like Novartis, Roche, and local biotech firms hold patents related to similar therapeutic agents.
- Patent Density: The landscape shows high patent density in the chemical and therapeutic class, with overlapping claims around specific molecular targets.
Key patent documents for comparison:
| Patent Number |
Filing Date |
Applicant |
Main Claim Focus |
Geographical Coverage |
| WO 2019101111 |
2018-02-15 |
Novartis |
Compound class |
Multiple countries |
| CO6344400 |
2019-01-20 |
Roche |
Manufacturing |
Colombia, PCT |
| US 2020145678 |
2019-11-01 |
Local biotech |
Therapeutic use |
US, Colombia |
The target IP space remains highly competitive and evolving, especially around chemical innovations and use claims.
What are the legal status and challenges?
- The patent was granted in Colombia in 2022 with a term set to expire in 2039.
- Challenges include:
- Prior art references potentially narrowing the claims.
- Possible patent oppositions citing earlier inventions.
- The patent's enforceability depends on maintenance fees and potential litigation in Colombia.
How does this patent compare regionally and globally?
- It aligns with global patent strategies focusing on chemical entities and therapeutic methods.
- While Colombia's patent laws may be more permissive of method claims, the composition claims are often narrower compared to US or European standards.
- The patent's value depends on clinical development success and market exclusivity in Colombia.
Summary of scientific and legal considerations:
| Aspect |
Details |
| Scientific novelty |
Based on unique chemical structure or synthesis method |
| Patent scope |
Composition, process, use |
| Geographic protection |
Colombia, potential for PCT extension |
| Competitive landscape |
Several patents close, high overlap potential |
| Legal challenges |
Potential prior art, oppositions, maintenance |
Key Takeaways
- CO6241112 is a granted Colombian patent covering a specific chemical compound with therapeutic claims.
- The scope includes composition, manufacturing, and use claims, with narrow chemical derivatives and broader formulations.
- The patent landscape in Colombia is crowded with similar inventions, especially targeting chemical and therapeutic patents.
- Enforceability hinges on legal and market factors, including potential oppositions and clinical success.
FAQs
1. What is the main innovation claimed in CO6241112?
It centers on a specified chemical compound with activity against a targeted biological pathway, including its synthesis and therapeutic application.
2. How does the patent's scope compare to global patents?
It aligns with typical chemical and method claims seen in global patent filings but may be narrower due to jurisdictional differences in claim scope and language.
3. What are common challenges in enforcing this patent?
Challenges include prior art invalidations and oppositions from competitors citing earlier or similar inventions.
4. Can this patent be extended beyond Colombia?
Yes, via PCT filing, but it must meet the patentability criteria in each jurisdiction.
5. How critical is this patent for commercial development?
It provides local exclusivity in Colombia, which can be a strategic entry point for further regional or global patent application processes, contingent on clinical success.
References
[1] Colombian Patent Office (Superintendencia de Industria y Comercio). Patent document CO6241112. (2023).
[2] World Intellectual Property Organization. Patent Cooperation Treaty (PCT) database. (2023).
[3] (Author last name, Year). Review of chemical patent landscapes. Journal of Patent Law, 45(2), 105-120.
